Antimicrobial Human beta-Defensins in the Colon and Their Role in Infectious and Non-Infectious Diseases

被引:57
作者
Cobo, Eduardo R. [1 ]
Chadee, Kris [1 ]
机构
[1] Univ Calgary, Fac Med, Snyder Inst Chron Dis, Dept Microbiol Immunol & Infect Dis,Gastrointesti, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada
关键词
innate immunity; antimicrobial peptides; beta-defensin; colon; intestinal mucosa; parasites; infection;
D O I
10.3390/pathogens2010177
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
beta-defensins are small cationic antimicrobial peptides secreted by diverse cell types including colonic epithelial cells. Human beta-defensins form an essential component of the intestinal lumen in innate immunity. The defensive mechanisms of beta-defensins include binding to negatively charged microbial membranes that cause cell death and chemoattraction of immune cells. The antimicrobial activity of beta-defensin is well reported in vitro against several enteric pathogens and in non-infectious processes such as inflammatory bowel diseases, which alters beta-defensin production. However, the role of beta-defensin in vivo in its interaction with other immune components in host defense against bacteria, viruses and parasites with more complex membranes is still not well known. This review focuses on the latest findings regarding the role of beta-defensin in relevant human infectious and non-infectious diseases of the colonic mucosa. In addition, we summarize the most significant aspects of beta-defensin and its antimicrobial role in a variety of disease processes.
引用
收藏
页码:177 / 192
页数:16
相关论文
共 50 条
  • [21] Antimicrobial peptides in the innate immunity of infectious diseases.
    Rivas-Santiago, B
    Sada, E
    Hernández-Pando, R
    Tsutsumi, V
    SALUD PUBLICA DE MEXICO, 2006, 48 (01): : 62 - 71
  • [22] Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome
    Mitaka, C
    CLINICA CHIMICA ACTA, 2005, 351 (1-2) : 17 - 29
  • [23] The role of the microbiota in infectious diseases
    Libertucci, Josie
    Young, Vincent B.
    NATURE MICROBIOLOGY, 2019, 4 (01) : 35 - 45
  • [24] Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium
    King, AE
    Fleming, DC
    Critchley, HOD
    Kelly, RW
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2003, 59 (01) : 1 - 16
  • [25] The Role of Glycosylation in Infectious Diseases
    Zhang, Xiao-Lian
    Qu, Haoran
    ROLE OF GLYCOSYLATION IN HEALTH AND DISEASE, 2021, 1325 : 219 - 237
  • [26] Novel Synthetic, Salt-Resistant Analogs of Human Beta-Defensins 1 and 3 Endowed with Enhanced Antimicrobial Activity
    Scudiero, Olga
    Galdiero, Stefania
    Cantisani, Marco
    Di Noto, Rosa
    Vitiello, Mariateresa
    Galdiero, Massimiliano
    Naclerio, Gino
    Cassiman, Jean-Jacques
    Pedone, Carlo
    Castaldo, Giuseppe
    Salvatore, Francesco
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2312 - 2322
  • [27] Antimicrobial Peptides and Innate Lung Defenses Role in Infectious and Noninfectious Lung Diseases and Therapeutic Applications
    Hiemstra, Pieter S.
    Amatngalim, Gimano D.
    van der Does, Anne M.
    Taube, Christian
    CHEST, 2016, 149 (02) : 545 - 551
  • [28] Endogenous antimicrobial factors in the treatment of infectious diseases
    Zelechowska, Paulina
    Agier, Justyna
    Brzezinska-Blaszczyk, Ewa
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 41 (04) : 419 - 425
  • [29] Adalimumab for the treatment of non-infectious uveitis: an updated review
    Kubaisi, Buraa
    Syeda, Sarah
    Schmidt, Alexander
    Foster, C. Stephen
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (02): : 201 - 206
  • [30] Non-infectious mechanisms of neurological damage due to infection
    Benninger, Felix
    Steiner, Israel
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 431